Officer Sale of ANI Pharmaceuticals Inc. Stock

2026-04-13SEC Filing 4 (0001938861-26-000013)

Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals Inc., reported the sale of 500 shares of Common Stock on April 13, 2026. The transaction was executed at a price of $77.95 per share, resulting in a post-transaction holding of 78,890 shares. This sale was conducted under a Rule 10b5-1 trading plan adopted on September 15, 2025. The filing is Form 4.